DUBLIN–(BUSINESS WIRE)–The “Global Aspiration & Biopsy Needles Market Size, Share & Industry Trends Analysis Report By Product Type, By Procedure, By Image-guided Type, By End User, By Application, By Tumor/ Cancer Applications Type, By Regional Outlook and Forecast, 2022-2028” report has been added to ResearchAndMarkets.com’s offering.
The Global Aspiration & Biopsy Needles Market size is expected to reach $1.3 billion by 2028, rising at a market growth of 6.1% CAGR during the forecast period.
A biopsy is a surgical operation that involves removing tissue from an organ to detect the existence or degree of a disease, most commonly cancer and inflammatory disorders. Surgeons, radiologists, and interventional cardiologists are the most common practitioners. As a confirmatory test for cancer and celiac disease, biopsies can be conducted on any organ using specialized biopsy instruments. The type of organ under consideration determines how each biopsy equipment is used.
Advanced imaging technologies, such as ultrasound-guided biopsy, MRI-guided biopsy, stereotactic-guided biopsy, CT scan, and others, can be used in conjunction with traditional biopsy techniques to perform a biopsy with accuracy and least invasiveness. Biopsies of body organs such as the liver, lungs, and kidneys are performed using these integrated methods.
Needle biopsy is a method of removing a sample of cells from the body by inserting a needle into the appropriate sampling area. The tissue is then examined in a laboratory to discover if it contains any abnormalities. A needle biopsy is used to determine the cause of symptoms such as a tumor, lump, inflammation, or infection. Computed tomography or ultrasound may be utilized in conjunction with a needle biopsy to provide more precise results.
To check anomalies at a specific location, radiologists and surgeons use biopsy needle techniques such as core-needle and fine-needle procedures. Increased demand for minimally invasive procedures, as well as cancer awareness programs run by governments and worldwide health organizations, are expected to drive Market growth throughout the forecast period.
Market driving Factors:
Rising Incidences of Cancer
There has been a spike in the number of people diagnosed with cancer around the world. This can be due to a variety of factors, including changes in lifestyle, bad diets, and increased cigarette use. According to the International Agency for Research on Cancer (IARC), 17.0 million new cancer cases and 9.5 million cancer deaths occurred globally in 2018. The global burden of cancer is anticipated to rise to 27.5 million new cases and 16.3 million deaths by 2040, owing to population expansion and aging.
Rising Demand in Emerging Countries
Disruptive business trends are expected as spanning from shifting supply chains to cost savings, automation, and a focus on customers. Companies that recognize and align their operations with industry trends will gain significant Market share. In the aspiration and biopsy needles Market, emerging Market s such as India, China, Brazil, and Mexico are expected to provide considerable growth potential for competitors. This can be ascribed to increased healthcare expenditures, improved living conditions, a broad target population base, improved and expanded healthcare infrastructure, and modernization of healthcare research and facilities in these countries.
Marketing Restraining Factor:
Reusing Aspiration and Biopsy Needles Poses Risk of Infection to Patients
Radiologists and surgeons use biopsy needle procedures such as core-needle and fine-needle procedures to examine anomalies at a specific spot. Patients may, however, get infections as a result of the cuts and incisions used to remove tissue samples. Furthermore, aspiration and biopsy needles are frequently reused, raising the infection risk during these procedures. Despite the fact that the reuse of some needles is discouraged by healthcare authorities and product manufacturers, the practice persists, particularly in developing nations.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
- Biopsy Needles
- Aspiration Needles
By Procedure
- Image-guided
- Nonimage-guided
By End User
- Hospitals & surgical centers
- Diagnostic Clinics & pathology laboratories
- Ambulatory care centers
- Research & Academic Institutes
By Application
- Tumor/ Cancer Applications
- Wound Applications
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
- Boston Scientific Corporation
- Medtronic PLC
- Johnson & Johnson
- Merit Medical Systems, Inc.
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- ConMed Corporation
- Olympus Corporation
- Argon Medical Devices, Inc.
- Cook Medical, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/azyx3p
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
